We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gene Logic Inc. announced that it has entered into a drug repositioning and development agreement with Eli Lilly and Company to seek alternative development paths for multiple Lilly drug candidates.
Most Alzheimer's patients prescribed antipsychotic drugs for delusions, agitation or aggression do no better than those who take a placebo because so many discontinue the drugs due to significant side effects, according to a major new nationwide study led by Lon Schneider, professor of psychiatry, neurology and gerontology at the Keck School of Medicine of the University of Southern California (USC).
AnorMed Inc. ruled Wednesday that a sweetened takeover bid by Genzyme Corp. is a "superior proposal" to its friendly takeover deal with Millennium Pharmaceuticals Inc.
U.S. District Judge Edward Korman harshly criticized the Food and Drug Administration at a Brooklyn court hearing, questioning its handling of a request to allow over-the-counter sales of a prescription emergency contraceptive.
One in three doctors believe that their decisions on which drugs to prescribe have been affected by receiving drug samples from pharmaceutical sales representatives, indicating that the practice needs to be examined more carefully, according to a study of doctors published in the Journal of Medical Ethics.
Close to half of the U.S. population does not fully understand the information on drug websites that target consumers, according to an analysis -- further evidence of "a serious, serious problem" in consumers' understanding of medicines and how to take them, according to one consumer advocate.
The pharmaceutical industry is wasting more than $50 billion each year through inadequate IT and misplaced decisionmaking, according to an academic study.
Last week the Florida Department of Health designated SupplyScape as the first company to provide digital certificates to help companies comply with the state's progressive pharmaceutical pedigree requirement.